Suchergebnisse - "Lenalidomide"

PubPharm (414)

1

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma

enthalten in: American journal of hematology | 2024

von Ludwig, H. | Melchardt, T. | Sormann, S. | +23

2

Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

enthalten in: Photodermatology, photoimmunology & photomedicine | 2024

von De Novellis, D. | Raimondo, A. | Serio, B. | +4

3

Four-Drug Therapy for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sampath, V.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

4

Four-Drug Therapy for Multiple Myeloma. Reply

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

5

Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?

enthalten in: Blood cancer journal | 2024

von Abdallah, M. | Reichard, K. | Gangat, N. | +1

6

Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma : Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study

enthalten in: American journal of hematology | 2024

von Gavriatopoulou, M. | Ntanasis-Stathopoulos, I. | Malandrakis, P. | +11

7

Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide

enthalten in: Joint bone spine | 2024

von Carvès, S. | Birsen, R. | Avouac, J.

8

Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy : a case report

enthalten in: Annals of hematology | 2023

von Li, C. | Zhang, X. | Zhu, D. | +3

9

B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature

enthalten in: Leukemia & lymphoma | 2023

von Arribas, I. | Maluquer, C. | Pomares, H. | +11

CommentIn: Leuk Lymphoma. 2023 Oct;64(10):1611-1614. - PMID 37671741

10

Vanishing bile duct syndrome in a patient with multiple myeloma treated with bortizomib, lenalidomide and dexamethasone

enthalten in: Clinics and research in hepatology and gastroenterology | 2023

von Filanovsky, K. | Temper, N. | Stanevsky, A. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]